Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 13787
Country/Region: Zambia
Year: 2015
Main Partner: Churches Health Association of Zambia
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $5,157,141 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $656,198
Care: TB/HIV (HVTB) $600,000
Care: Pediatric Care and Support (PDCS) $300,000
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $122,164
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $107,968
Testing: HIV Testing and Counseling (HVCT) $465,811
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $400,000
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $2,000,000
Treatment: Pediatric Treatment (PDTX) $505,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Age/sex: <1 Female 2016 1,528
CARE_CURR Age/sex: <1 Male 2016 1,485
CARE_CURR Age/sex: 1-4 Female 2016 1,812
CARE_CURR Age/sex: 1-4 Male 2016 3,042
CARE_CURR Age/sex: 10-14 Female 2016 3,412
CARE_CURR Age/sex: 10-14 Male 2016 3,331
CARE_CURR Age/sex: 15-19 Female 2016 2,398
CARE_CURR Age/sex: 15-19 Male 2016 4,239
CARE_CURR Age/sex: 20-24 Female 2016 4,874
CARE_CURR Age/sex: 20-24 Male 2016 3,505
CARE_CURR Age/sex: 25-49 Female 2016 3,827
CARE_CURR Age/sex: 25-49 Male 2016 1,670
CARE_CURR Age/sex: 5-9 Female 2016 1,844
CARE_CURR Age/sex: 5-9 Male 2016 1,897
CARE_CURR Age/sex: 50+ Female 2016 381
CARE_CURR Age/sex: 50+ Male 2016 381
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 8,045
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 9,123
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 10,836
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 9,218
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 39,532
CARE_CURR Sum of Age/Sex disaggregates 2016 39,626
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 37,222
CARE_NEW Age/sex: <1 Female 2016 259
CARE_NEW Age/sex: <1 Male 2016 247
CARE_NEW Age/sex: 1-4 Female 2016 271
CARE_NEW Age/sex: 1-4 Male 2016 461
CARE_NEW Age/sex: 10-14 Female 2016 509
CARE_NEW Age/sex: 10-14 Male 2016 574
CARE_NEW Age/sex: 15-19 Female 2016 384
CARE_NEW Age/sex: 15-19 Male 2016 734
CARE_NEW Age/sex: 20-24 Female 2016 796
CARE_NEW Age/sex: 20-24 Male 2016 632
CARE_NEW Age/sex: 25-49 Female 2016 612
CARE_NEW Age/sex: 25-49 Male 2016 241
CARE_NEW Age/sex: 5-9 Female 2016 325
CARE_NEW Age/sex: 5-9 Male 2016 327
CARE_NEW Age/sex: 50+ Female 2016 40
CARE_NEW Age/sex: 50+ Male 2016 83
CARE_NEW Aggregated Age/sex: <15 Female 2016 1,280
CARE_NEW Aggregated Age/sex: <15 Male 2016 1,503
CARE_NEW Aggregated Age/sex: 15+ Female 2016 1,724
CARE_NEW Aggregated Age/sex: 15+ Male 2016 1,593
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 6,495
CARE_NEW Sum of Age/sex disaggregates 2016 6,495
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 6,100
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 6,100
FPINT_SITE Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2016 5
FPINT_SITE Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2016 11
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 1,330
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 1,519
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 8,788
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 8,233
HTS_TST By Test Result: Negative 2016 22,206
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 22,870
HTS_TST Sum of Aggregated Age/Sex <15 2016 2,849
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 17,021
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 19,870
HTS_TST Sum of Test Result disaggregates 2016 24,670
HTS_TST_POS By Test Result: Positive 2016 2,464
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 213
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 239
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 165
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 74
PMTCT_ARV Sum of New and Current disaggregates 2016 239
PMTCT_EID By infants who received a virologic test within 2 months of birth 2016 149
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 78
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 227
PMTCT_EID Sum of Infant Age disaggregates 2016 227
PMTCT_STAT By: Known positives at entry 2016 191
PMTCT_STAT By: Number of new positives identified 2016 95
PMTCT_STAT Number of new ANC and L&D clients 2016 6,765
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 6,765
PMTCT_STAT Sum of Positives Status disaggregates 2016 286
PP_PREV Age/sex: 10-14 Female 2016 104
PP_PREV Age/sex: 10-14 Male 2016 104
PP_PREV Age/sex: 15-19 Female 2016 273
PP_PREV Age/sex: 15-19 Male 2016 248
PP_PREV Age/sex: 20-24 Female 2016 158
PP_PREV Age/sex: 20-24 Male 2016 152
PP_PREV Age/sex: 25-49 Female 2016 151
PP_PREV Age/sex: 25-49 Male 2016 130
PP_PREV Age/sex: 50+ Female 2016 26
PP_PREV Age/sex: 50+ Male 2016 34
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 1,380
PP_PREV Sum of Age/Sex disaggregates 2016 1,380
PP_PREV Total number of people in the target population 2016 798,006
TB_ART Aggregated Age: <15 2016 79
TB_ART Aggregated Age: 15+ 2016 298
TB_ART Female 2016 237
TB_ART Known HIV-positive 2016 257
TB_ART Male 2016 315
TB_ART Sum of Aggregated Age disaggregates 2016 377
TB_ART Sum of Sex disaggregates 2016 552
TB_ART Sum of Test Status disaggregates 2016 257
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 601
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 552
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 39,532
TX_CURR Age/Sex: <1 Female 2016 164
TX_CURR Age/Sex: <1 Male 2016 156
TX_CURR Age/Sex: 1-4 Female 2016 195
TX_CURR Age/Sex: 1-4 Male 2016 188
TX_CURR Age/Sex: 5-14 Female 2016 353
TX_CURR Age/Sex: 5-14 Male 2016 352
TX_CURR Aggregated Age/Sex: <1 Female 2016 114
TX_CURR Aggregated Age/Sex: <1 Male 2016 110
TX_CURR Aggregated Age/Sex: 15+ Female 2016 2,747
TX_CURR Aggregated Age/Sex: 15+ Male 2016 1,679
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 25,331
TX_CURR Sum of age/sex disaggregates 2016 25,331
TX_CURR Sum of Aggregated Age/Sex (<1 and 1-14) <15 2016 504
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 4,426
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 4,426
TX_NEW Aggregated Grouping by Age: <1 Male 2016 201
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2016 201
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 1,592
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 1,476
TX_NEW Breastfeeding status 2016 130
TX_NEW By Age/Sex: <1 Female 2016 201
TX_NEW By Age/Sex: <1 Male 2016 201
TX_NEW By Age/Sex: 1-4 Female 2016 227
TX_NEW By Age/Sex: 1-4 Male 2016 348
TX_NEW By Age/Sex: 10-14 Female 2016 463
TX_NEW By Age/Sex: 10-14 Male 2016 455
TX_NEW By Age/Sex: 15-19 Female 2016 329
TX_NEW By Age/Sex: 15-19 Male 2016 656
TX_NEW By Age/Sex: 20-24 Female 2016 740
TX_NEW By Age/Sex: 20-24 Male 2016 520
TX_NEW By Age/Sex: 25-49 Female 2016 485
TX_NEW By Age/Sex: 25-49 Male 2016 274
TX_NEW By Age/Sex: 5-9 Female 2016 208
TX_NEW By Age/Sex: 5-9 Male 2016 210
TX_NEW By Age/Sex: 50+ Female 2016 39
TX_NEW By Age/Sex: 50+ Male 2016 26
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 5,382
TX_NEW Pregnancy status 2016 125
TX_NEW Sum of Age/Sex disaggregates 2016 5,382
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 3,068
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 4,188
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 5,112
VMMC_AE Number of males circumcised surgically or by medical device that experienced at least one moderate or severe adverse event(s) (AEs) 2016 62
VMMC_CIRC By Age: 10-14 2016 368
VMMC_CIRC By Age: 15-19 2016 2,249
VMMC_CIRC By Age: 20-24 2016 1,986
VMMC_CIRC By Age: 50+ 2016 22
VMMC_CIRC By circumcision technique: Surgical VMMC 2016 6,154
VMMC_CIRC By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2016 5,974
VMMC_CIRC By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site 2016 264
VMMC_CIRC By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2016 5,170
VMMC_CIRC By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2016 720
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2016 6,154
VMMC_CIRC Sum of age disaggregates 2016 4,625